Nothing Special   »   [go: up one dir, main page]

Mandal et al., 2015 - Google Patents

Polymer-based synthetic dendritic cells for tailoring robust and multifunctional T cell responses

Mandal et al., 2015

View PDF
Document ID
3158077594319131999
Author
Mandal S
Hammink R
Tel J
Eksteen-Akeroyd Z
Rowan A
Blank K
Figdor C
Publication year
Publication venue
ACS Chemical Biology

External Links

Snippet

Dendritic cells (DCs) are antigen-presenting cells that play an essential role in T cell activation. Recent efforts in cancer immunotherapy have been directed at the development of artificial antigen presenting cells (aAPCs) loaded with tumor antigens. These aAPCs are …
Continue reading at repository.ubn.ru.nl (PDF) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form

Similar Documents

Publication Publication Date Title
Mandal et al. Polymer-based synthetic dendritic cells for tailoring robust and multifunctional T cell responses
Zhang et al. Nanoparticle size influences antigen retention and presentation in lymph node follicles for humoral immunity
Meng et al. Ultrasound-mediated remotely controlled nanovaccine delivery for tumor vaccination and individualized cancer immunotherapy
Hickey et al. Biologically inspired design of nanoparticle artificial antigen-presenting cells for immunomodulation
Yin et al. Engineered macrophage-membrane-coated nanoparticles with enhanced PD-1 expression induce immunomodulation for a synergistic and targeted antiglioblastoma activity
Ogunnaike et al. Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastoma
Hammink et al. Controlling T-cell activation with synthetic dendritic cells using the multivalency effect
Wilson et al. Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes
Park et al. Modulation of CD4+ T lymphocyte lineage outcomes with targeted, nanoparticle-mediated cytokine delivery
Flacher et al. Murine Langerin+ dermal dendritic cells prime CD 8+ T cells while L angerhans cells induce cross‐tolerance
Chin et al. A hydrogel-integrated culture device to interrogate T cell activation with physicochemical cues
Kim et al. Poly (cyclodextrin)‐Polydrug Nanocomplexes as Synthetic Oncolytic Virus for Locoregional Melanoma Chemoimmunotherapy
Cardle et al. Biomaterials in chimeric antigen receptor T-cell process development
Hammink et al. Semiflexible immunobrushes induce enhanced T cell activation and expansion
Li et al. Rational design of T-cell-and B-cell-based therapeutic cancer vaccines
Cheng et al. Recombination monophosphoryl lipid A-derived vacosome for the development of preventive cancer vaccines
Yang et al. RBD-modified bacterial vesicles elicited potential protective immunity against SARS-CoV-2
Wen et al. Engineering protein delivery depots for cancer immunotherapy
Temples et al. Engineered three-dimensional tumor models to study natural killer cell suppression
Jie et al. Customized multifunctional peptide hydrogel scaffolds for CAR-T-cell rapid proliferation and solid tumor immunotherapy
Slezak et al. Tumor cell-surface binding of immune stimulating polymeric glyco-adjuvant via cysteine-reactive pyridyl disulfide promotes antitumor immunity
Weiss et al. Direct in vivo activation of T cells with nanosized immunofilaments inhibits tumor growth and metastasis
Wang et al. Cellular bioparticulates with therapeutics for cancer immunotherapy
Ou et al. One-Dimensional Rod-like Tobacco Mosaic Virus Promotes Macrophage Polarization for a Tumor-Suppressive Microenvironment
Froimchuk et al. Biophysical properties of self-assembled immune signals impact signal processing and the nature of regulatory immune function